Skip to main content
. 2012 Aug;14(4):364–376. doi: 10.1089/cell.2012.0001

FIG. 4.

FIG. 4.

FIG. 4.

Specific ESC markers, gene expression, and karyotyping results of putative rbESCs derived and maintained under Condition II. Putative rbESC lines (R4, R9, R15, R21, and R31) derived and maintained under Condition II (REF+rbLIF) are positive for AP (A, top panel) and other pluripotency markers, including Oct-4, Nanog, Sox2, and SSEA4 (B, lower panels). (A) Representative staining images of R4 (passage 7). RT-PCR assays revealed that these cell lines (R4, passage 7; R9, passage 6; R15, passage 4; R21, passage 5; and R31, passage 4) expressed pluripotency genes such as Oct-4, Sox-2, Nanog, c-Myc, Klf4, and Dppa5 (B). GAPDH was used as the internal control. Karyotyping analysis on line R4 (passage 15) and line M5 (passage 15) revealed 57.5% and 60.0% normal ploidy rates, respectively (C). Both R4 (D and E) and M5 (images not shown) were identified as male cell lines. Scale bars, 200 μm.